Journal of Addiction Medicine Announces New Editor-in-Chief
On November 2nd, 2022, the American Society of Addiction Medicine (ASAM) named David A. Fiellin, MD, FASAM, the next editor-in-chief of its Journal of Addiction Medicine (JAM).
Dr. Fiellin is an internist, board-certified in addiction medicine. He is professor of Medicine and Emergency Medicine at Yale School of Medicine, and Public Health at Yale School of Public Health; vice chief of Faculty Affairs for the Department of Internal Medicine’s Section of General Internal Medicine; and serves as the inaugural director of the Program in Addiction Medicine at Yale.
Dr. Fiellin will begin the leadership position in January of 2023, when the acting interim editor-in-chief, renowned researcher, Frank J. Vocci, PhD, steps down to focus on research related to developing medications for the treatment of substance use disorders. Dr. Fiellin will join current journal co-editors, Drs. Kelly E. Dunn, Ismene Petrakis, and Frank J. Vocci, and acting co-editors Benjamin H. Han and Marcela Smid. Click here to read the full press release.